Effects of milk proteins on gut and stomach symptoms

Not Applicable

Completed

• Conditions: Functional gastrointestinal disorders including irritable bowel syndrome, functional dyspepsia/bloating and functional diarrhea; Digestive System

• Registration Number: ISRCTN74158117
• Lead Sponsor: Valio Oyj Ltd

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32708428/ (added 02/12/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-11
• Study Completion: 2019-11-11
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

1. Aged between 18 and 65 years
2. Irritable bowel syndrome, functional dyspepsia/bloating and functional diarrhea (all defined by Rome IV criteria)

Exclusion Criteria

1. Organic gastrointestinal disease such as Crohn's disease, ulcerative colitis, colorectal or gastric or any cancer
2. Pregnancy or breastfeeding
3. Significant abdominal surgery (e.g. bowel resection)
4. Difficult to treat constipation
5. Medication that affects intestinal motility and/or pain perception

Study & Design

• Study Type: Interventional
• Study Design: Not specified